Drug & supplement interaction

Tetrahydrocannabivarin (thcv) + Pralsetinib

Pralsetinib brand name: Gavreto.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Tetrahydrocannabivarin (thcv) and Pralsetinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the label for Pralsetinib states a food rule worth keeping to.

Know someone taking this? Share
Interaction report

Tetrahydrocannabivarin (thcv) and Pralsetinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Pralsetinib and Tetrahydrocannabivarin (thcv) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Tetrahydrocannabivarin (thcv) at all — not against Pralsetinib, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Tetrahydrocannabivarin (thcv) safety at a glance

Tetrahydrocannabiv... overall Use caution Human safety data are limited, and product quality and legality vary a lot.
Pregnancy Avoid Cannabis-derived compounds are not considered safe in pregnancy.
Breastfeeding Avoid Cannabinoids can pass into breast milk, so avoid use while nursing.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Pralsetinib and Tetrahydrocannabivarin (thcv)? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Pralsetinib’s Own FDA Label Lists

This is not an interaction — none of it involves Tetrahydrocannabivarin (thcv). These are the most notable effects listed in the ADVERSE REACTIONS section of Pralsetinib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • Low sodium Worth acting on
  • Blood clots Worth acting on
  • Yellowing of the skin or eyes Worth acting on
  • Fainting Worth acting on
  • Anemia Worth acting on mentioned in 5.5% of FDA reports for Pralsetinib
  • Raised blood pressure Worth acting on mentioned in 5.6% of FDA reports for Pralsetinib
  • Seizures Worth acting on
  • Chest pain Worth acting on
  • A low platelet count Worth acting on
  • Kidney problems Worth acting on

Showing the 10 most notable of 40 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Pralsetinib. Read the label on DailyMed › Where a percentage is shown, it is the share of 1,699 voluntary FDA FAERS reports for Pralsetinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Tetrahydrocannabivarin (thcv)’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Tetrahydrocannabivarin (thcv) side to compare — that is a limit of the record, not a statement that Tetrahydrocannabivarin (thcv) has no side effects.

How to take them

Some Pralsetinib Products Have a Food Rule — Tetrahydrocannabivarin (thcv) Should Not Break It

At least one FDA label for a product containing Pralsetinib says to take it on an empty stomach. Most supplements — Tetrahydrocannabivarin (thcv) included — are taken with a meal, so the easy mistake is swallowing both together at breakfast. Where that rule applies, keep Pralsetinib on its own and move Tetrahydrocannabivarin (thcv) to a meal later in the day.

This may not be true of your version. Food instructions belong to the product, not the ingredient: two Pralsetinib products can carry different directions, and extended-release forms often differ from immediate-release ones. The label we read is quoted below — check the directions on your own box or bottle, or ask your pharmacist, for how to take the exact product you were given.

( 2.1 , 14 ) The recommended dosage in adults and pediatric patients 12 years and older is 400 mg orally once daily on an empty stomach (no food intake for at least 2 hours before and at least 1 hour after taking GAVRETO).

From the Dosage and Administration section of the FDA label we read for Pralsetinib — where that label names a specific product, the instruction is that product's. Read the label on DailyMed ›

A food rule is not an interaction — it is about how much of the medicine you absorb. The directions that came with your own product, and your pharmacist, outrank anything on this page.

Everything else you take

See Every Supplement That Interacts With Pralsetinib

This page covers Tetrahydrocannabivarin (thcv) only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Pralsetinib page lists 181 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), American Hellebore (major), Arsenic (major), Beer (major) and Cesium (major).

By severity: 11 major · 134 moderate · 36 minor.

From our pharmacist’s overview on the Pralsetinib page

“With pralsetinib (Gavreto), a targeted therapy for RET-driven lung and thyroid cancers, I would treat this list as required reading rather than background noise. Most of the interactions change how much of the drug the body actually gets: grapefruit can push its levels higher, while St.”

Reviewed by 2 · Jul 18, 2026

Open the Pralsetinib interaction page

How much people look this up

Where Tetrahydrocannabivarin (thcv) and Pralsetinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Tetrahydrocannabivarin (thcv)
Steady interest

#927 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Pralsetinib
Steady interest

#2,313 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Tetrahydrocannabivarin (thcv) is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Tetrahydrocannabivarin (thcv) reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Tetrahydrocannabivarin (thcv) and Pralsetinib records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Tetrahydrocannabivarin (thcv)

What is Tetrahydrocannabivarin (thcv)?

  • Appetite control and weight management
  • Blood sugar support
  • Energy and focus
  • General wellness

Tetrahydrocannabivarin (THCV) is a minor cannabinoid found in cannabis that is being studied for appetite, metabolism, and blood sugar, but human evidence is very limited. Product quality, legal status, and dosing vary widely, so talk with your pharmacist or doctor before trying it, and avoid it during pregnancy and breastfeeding.

Cannabis sativa · Cannabaceae · Flowers and leaves of the cannabis plant (THCV is an extracted or isolated cannabinoid) · Oils, tinctures, capsules, gummies, vape products, and isolated extracts

An interaction check asks whether these two react with each other — it does not ask whether Tetrahydrocannabivarin (thcv) is a good idea for someone in your situation. Here is what our Tetrahydrocannabivarin (thcv) record says about it on its own.

Tetrahydrocannabivarin (thcv): dosing

There is no established standard dose for THCV. Research is too limited to recommend a specific milligram amount, and effects may even differ between low and high doses.If you choose to try a product, follow the directions on the label and start with the lowest amount.

From our Tetrahydrocannabivarin (thcv) monograph — the full record covers uses, side effects and every documented interaction.

Read the full Tetrahydrocannabivarin (thcv) monograph & all interactions
Medication

About Pralsetinib

What Is Pralsetinib Used For?

Brand name: Gavreto

Gavreto (pralsetinib) is used to treat adults with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) — a type of lung cancer that has spread and carries a specific genetic alteration detected by an FDA-approved test.

Gavreto is also approved for adults and children aged 12 and older with advanced or metastatic RET fusion-positive thyroid cancer who need systemic (whole-body) treatment and whose cancer no longer responds to radioactive iodine (when radioactive iodine is an appropriate option). This thyroid cancer use is under accelerated approval, meaning continued approval depends on results from confirmatory clinical trials.

Most-Reported Side Effects for Pralsetinib

From FAERS, the FDA’s public side-effect reporting system (1,788 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Product prescribing issue 181 reports
Fatigue 126 reports
Asthenia 116 reports
Anemia 98 reports
Hypertension 96 reports
See full Pralsetinib drug information
Keep checking

Other Drugs & Tetrahydrocannabivarin (thcv)

Browse every other medication we’ve checked against Tetrahydrocannabivarin (thcv) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Tetrahydrocannabivarin (thcv) References

The 2 sources that drive our Tetrahydrocannabivarin (thcv) monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Tetrahydrocannabivarin (thcv) is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Cannabis (Marijuana) and Cannabinoids: What You Need To Know — NIH NCCIH Source
  2. Marijuana — MedlinePlus Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Tetrahydrocannabivarin (thcv) and Pralsetinib Together: Common Questions

Is it safe to take Tetrahydrocannabivarin (thcv) with Pralsetinib?
We do not list a known interaction between Tetrahydrocannabivarin (thcv) and Pralsetinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Should I take Tetrahydrocannabivarin (thcv) and Pralsetinib at the same time of day?
At least one FDA label for a product containing Pralsetinib says to take it on an empty stomach, and supplements are usually taken with a meal — so taking them together at breakfast is the easy mistake. Where that applies, keep Pralsetinib on its own and move Tetrahydrocannabivarin (thcv) to a meal later in the day. Food instructions belong to the product rather than the ingredient, so check the directions on your own box. This is about absorption, not an interaction.
Does Pralsetinib interact with any supplements?
Yes. Pralsetinib has documented interactions with 181 supplements in our database — Tetrahydrocannabivarin (thcv) is not one of them. The Pralsetinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Pralsetinib and Tetrahydrocannabivarin (thcv)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.